编辑推荐——择期腹主动脉瘤修复术后吸烟的患病率及其对围手术期结局的影响
基于英国国家血管注册库2014至2021年26916例择期肾下腹主动脉瘤修复患者,吸烟率21.9%、既往吸烟62.2%、不吸烟15.9%,吸烟率未随时间下降且医院间差异达2.4倍;与不吸烟者相比,吸烟与总体及呼吸系统并发症、肢体缺血、肠缺血、重返手术室和重症监护入住增加相关,住院死亡率无显著差异。
要点
- 择期腹主动脉瘤修复患者中当前吸烟者占21.9%,2014至2021年吸烟率未见下降。
- 与不吸烟者相比,吸烟与总体并发症(OR 1.40)、呼吸系统并发症(OR 1.98)等增加相关。
- 住院死亡率在吸烟者、既往吸烟者与不吸烟者间无显著差异(所有比较p > .050)。
核心结论
- 择期腹主动脉瘤修复患者中吸烟率仍高,2014至2021年当前吸烟者比例与英国一般人群相比未见下降证据。
- 吸烟与围手术期并发症发生率增加相关。
研究设计与样本
- 观察性队列研究,检索英国国家血管注册库中2014至2021年接受择期肾下腹主动脉瘤修复的成人。
- 共纳入26916例患者,其中吸烟者21.9%、既往吸烟者62.2%、不吸烟者15.9%。
- 所有分析均使用经验证的英国动脉瘤修复评分进行校正。
主要发现
- 吸烟率未随时间变化,英国各医院间差异达2.4倍(排除离群值后范围13.0-31.8%)。
- 住院死亡率在吸烟者、既往吸烟者与不吸烟者间无显著差异(所有比较p > .050)。
- 与不吸烟者相比,吸烟与总体并发症(OR 1.40,95%CI 1.24-1.57)、呼吸系统并发症(OR 1.98,95%CI 1.63-2.39)、肢体缺血(OR 1.63,95%CI 1.19-2.23)、肠缺血(OR 1.64,95%CI 1.06-2.54)、重返手术室(OR 1.38,95%CI 1.11-1.71)和重症监护入住(OR 1.43,95%CI 1.31-1.56)增加相关。
- 与既往吸烟者相比,吸烟与总体并发症(OR 1.24,95%CI 1.14-1.36)、呼吸系统并发症(OR 1.44,95%CI 1.27-1.63)、肢体缺血并发症(OR 1.48,95%CI 1.19-1.84)和重症监护入住(OR 1.37,95%CI 1.28-1.46)增加相关。
- 在血管腔内动脉瘤修复亚组分析中,当前吸烟与肢体缺血发生率显著高于既往吸烟者(OR 2.12,95%CI 1.49-3.01)和不吸烟者(OR 1.94,95%CI 1.19-3.16)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The contemporary burden of smoking in patients undergoing elective abdominal aortic aneurysm (AAA) repair in the UK is unknown. This study aimed to quantify the prevalence of smoking in patients undergoing AAA repair in the UK and determine the association between smoking and peri-operative outcomes. METHODS: This was an observational cohort study. The National Vascular Registry was interrogated for adults undergoing elective infrarenal AAA repair from 2014 to 2021 for prevalence of current smokers, former smokers, and non-smokers over time. The primary outcomes were post-operative complications by smoking status. Secondary outcomes were variation in smoking rates over time and by hospital, in hospital mortality, and length of stay by smoking status. All analyses were adjusted using the validated British Aneurysm Repair score. RESULTS: Overall, 26 916 patients undergoing elective AAA repair were included (21.9% smokers, 62.2% former smokers, 15.9% non-smokers). The prevalence of smoking did not change over time, with a 2.4 fold variation between UK hospitals (range 13.0 - 31.8% excluding outliers). In hospital mortality was not significantly different between smokers, former smokers, and non-smokers (p > .050 for all comparisons). Compared with non-smokers, smoking was associated with increased overall (odds ratio [OR] 1.40, 95% confidence interval [CI] 1.24 - 1.57) and respiratory complications (OR 1.98, 95% CI 1.63 - 2.39), limb ischaemia (OR 1.63, 95% CI 1.19 - 2.23), bowel ischaemia (OR 1.64, 95% CI 1.06 - 2.54), return to theatre (OR 1.38, 95% CI 1.11 - 1.71), and intensive care admission (OR 1.43, 95% CI 1.31 - 1.56). Compared with former smokers, smoking was associated with increased overall (OR 1.24, 95% CI 1.14 - 1.36), respiratory (OR 1.44, 95% CI 1.27 - 1.63) and limb ischaemia complications (OR 1.48, 95% CI 1.19 - 1.84), and intensive care admission (OR 1.37, 95% CI 1.28 - 1.46). On analysis of the endovascular aneurysm repair subgroup, active smoking was associated with significantly higher rates of limb ischaemia compared with former and non-smokers (OR 2.12, 95% CI 1.49 - 3.01 and OR 1.94, 95% CI 1.19 - 3.16 respectively). CONCLUSION: The prevalence of smoking remains high in patients undergoing elective AAA repair with no evidence of a decline in active smokers from 2014 to 2021 compared with the general UK population. Smoking is associated with increased peri-operative complication rates.
引用
- Wong KHF, Mouton R, Hinchliffe RJ, et al. Editor's Choice - Prevalence of Smoking and Impact on Peri-Operative Outcomes After Elective Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2024. PMID: 38295938. doi:10.1016/j.ejvs.2024.01.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。